Article Details

Protagonist Therapeutics shares slid after sharing Phase 2 data for its experimental ... - MarketWatch

Retrieved on: 2022-04-26 12:44:05

Tags for this article:

Click the tags to see associated articles and topics

Protagonist Therapeutics shares slid after sharing Phase 2 data for its experimental ... - MarketWatch. View article details on hiswai:

Excerpt

Biotechnology. Protagonist Therapeutics shares slid after sharing Phase 2 data for its experimental ulcerative colitis treatment.

Article found on: www.marketwatch.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up